Lesson from Super Investors πŸ‘‡πŸΌ
Case Study #1
Company: Mastek
Super Investor: Ashish Kacholia aka @LuckyInvest_AK

@LuckyInvest_AK is praised for his stock picks in a bull market.

Very few realize the patience and temperament required to hold through a stock position in a bear market.
As per public filings, we know Ashish sir, picked up a 1.73% stake in @Mastekltd sometime between Jun and Sep of 2018.
This was during the height of previous small cap rally in India.
Nifty Small cap index hit a high of 9665 in Jan 2018.

Post hitting that high, the index collapsed almost 20% in next six months by Aug 2018
(It collapsed even more later)

PS: The previous high of Nifty Small Cap from 2018 was just broken last month in Jun 2021!
During the same period of time, Mastek went against the index and rose almost 50% from Jan 2018 to Aug 2018.
This is the time around which Ashish sir started buying Mastek to increase his position above a 1% and appear in public filings.

Based on his filings, his transaction price must have been anywhere between Rs 500 and Rs 600 per share.
I am sure he did his research before buying, an experienced investor like him would have even used technical analysis to buy at the right possible price.

Usually when an investor like him adds to a position, the market rewards by moving the stock 10% higher.
So surely, the stock priced moved up and he got timing of everything correctly.

Wrong.
This is what Mastek stock price did over the next 20 months (almost 2 years!)

It went from Rs 600 odd to finally touching bottom of Rs 175 in Mar of 2020

A 70% Drawdown!
So what did Ashish sir do?

He bought more till he had bought about 2.89% of the company and then stayed put.
He didn't pay attention to what the stock price was doing.

Because while the stock was moving down, business stayed constant and even showed some improvement.
From Sep 2018 to Mar 2020, Sales and Margin remained stable and didn't bear the same decline as witnessed by the stock.
Meanwhile, Mastek was reshuffling its business.

It hived off its insurance arm called Majesco and sold that to raise cash.

Using that cash, it bought a cloud service company called Evosys.
Its because of those events and actions of Mastek's management from 2018 to 2020, you see Mastek's sales doubling and margin rising to 22%.

Major rise in sales and margin today is because of Evosys business.
Meanwhile, from Mar 2020, the stock price has moved from its low of 170/share to its recent high of 2350/share.

That's a gain of more than 12x
So what are the lessons we can learn here?

1⃣ Bull Markets can change anytime
2⃣ No one can time the market, not even super investors
3⃣ Those who put in work to research a business, will reap the reward
4⃣ Bear Markets, will test you
5⃣ Real wealth is build over long term
Look at your portfolio, will you be able to hold through your holding with a 70% Drawdown for years?

Do you know your holding really well?
Do you have the patience and temperament for the same?

Mastek went to a PE of 3.9!

Will you be able to digest that if it happens to you?
To Ashish sir and his mic dropping investments! πŸ‘πŸΌ

β€’ β€’ β€’

Missing some Tweet in this thread? You can try to force a refresh
γ€€

Keep Current with Tar ⚑

Tar ⚑ Profile picture

Stay in touch and get notified when new unrolls are available from this author!

Read all threads

This Thread may be Removed Anytime!

PDF

Twitter may remove this content at anytime! Save it as PDF for later use!

Try unrolling a thread yourself!

how to unroll video
  1. Follow @ThreadReaderApp to mention us!

  2. From a Twitter thread mention us with a keyword "unroll"
@threadreaderapp unroll

Practice here first or read more on our help page!

More from @itsTarH

30 Jun
So many updates on #SequentScientific Results, almost none focus on the most important metric

Net profit before tax and exceptional items (True Cash earned by the company) increase by ~55% YoY
ROCE now above 20% and PAT increase by 36.5% are signs of Operating Leverage

Before Op Leverage kicked in for Laurus, its ROCE was in ~14%
The Advisor onboarded created the animal healthcare business for Boehringer Ingelheim (~2nd largest animal healthcare business in the world with net sales of ~4.5 Billion+ and presence in over 150 countries
Read 4 tweets
24 Jun
The Oil drop in Reliance Logo has been replaced with a leaf #RelianceAGM
Okay, that's the foundations logo.
Moving on.

50% of EBITDA came from consumer business. Reliance is no longer an oil and chemical company.
Reliance Retail is 6x the size of next competitor in organized retail.

It's a shame that Walmart and not Reliance acquired Flipkart.
Read 15 tweets
20 Jun
It's the weekend!

Grab a cup of coffee, in this thread I will explain

1. What is index investing?
2. Why S&P 500, Nasdaq 100 and DIJA are different?
3. How to create your own indexes?

Let's dive right in.
You may have noticed at the start of every book, there is a page which lists out various chapters and the page number for each chapter.

This is called the index of contents of the book.

It helps you understand what is where and give you a general idea how to read the book.
Similarly in the world of finance, we have financial indexes that are used to indicate where the overall market is trading.

Is it high or is it low?
Is it cheap or is it expensive?

These questions can be answered by looking at the index.
Read 35 tweets
16 Jun
@IndiaRatings published its latest report on #SequentScientific

Here are the key parts πŸ‘‡πŸΌπŸ‘¨πŸΌβ€πŸ”¬
Sequent has been on a product launch spree.
With the only USFDA approved animal only dedicated facility in India, sequent has commercialized

πŸ§ͺ 32 APIs
πŸ“œ Filed 23 DMFs
πŸ₯ƒ Pipeline for 35 Formulations
Majority of these products are in high margin injectable business.

Sequent also acquired a Germany based R&D business which will further strengthen its R&D Pipeline.
Read 5 tweets
14 Jun
Wuxi Biologics Revenue (in CNY)
2017: 1.6 Billion
2018: 2.5 Billion
2019: 4 Billion
2020: 5.6 Billion

Has a backlog of orders worth USD 11 Billion+
Various stages and potential revenue in each stage for a CDMO
Even after increasing their capacity at a rapid pace, Wuxi still has a backlog which is growing at 50% per year.

Imagine the demand for a Biologics CDMO in the industry.
Read 4 tweets
12 Jun
Its the weekend!

Grab a cup of coffee, in this thread I will explain

1. What are Porter's 5 Forces?
2. How to use them while analyzing a business?
3. What information can they tell you about a business

We will be analyzing Divis Labs as an example.

Lets dive right in.
Michael Porter, is a business and economics professor at Harvard Business School. He is the author of more than 20 best sellers, all written on the topics of competitive advantage, his expertise.

He is most famous for his work on 5 force model which was first published in 1979.
Porter's 5 Force model is used to identify competitive advantages a company has amongst its peers and in an industry it operates in.

A simple 5 point analysis can help anyone determine whether a company enjoys certain advantages that its peers do not have.
Read 32 tweets

Did Thread Reader help you today?

Support us! We are indie developers!


This site is made by just two indie developers on a laptop doing marketing, support and development! Read more about the story.

Become a Premium Member ($3/month or $30/year) and get exclusive features!

Become Premium

Too expensive? Make a small donation by buying us coffee ($5) or help with server cost ($10)

Donate via Paypal Become our Patreon

Thank you for your support!

Follow Us on Twitter!

:(